Janney Montgomery Scott LLC decreased its position in shares of Masimo Co. (NASDAQ:MASI) by 44.0% during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 8,436 shares of the medical equipment provider’s stock after selling 6,617 shares during the quarter. Janney Montgomery Scott LLC’s holdings in Masimo were worth $1,051,000 as of its most recent SEC filing.
Other large investors have also recently bought and sold shares of the company. United Services Automobile Association lifted its stake in shares of Masimo by 0.7% in the 2nd quarter. United Services Automobile Association now owns 71,510 shares of the medical equipment provider’s stock valued at $6,983,000 after purchasing an additional 485 shares during the period. US Bancorp DE lifted its stake in shares of Masimo by 36.9% in the 2nd quarter. US Bancorp DE now owns 1,980 shares of the medical equipment provider’s stock valued at $193,000 after purchasing an additional 534 shares during the period. Oregon Public Employees Retirement Fund lifted its stake in shares of Masimo by 3.0% in the 2nd quarter. Oregon Public Employees Retirement Fund now owns 18,628 shares of the medical equipment provider’s stock valued at $1,819,000 after purchasing an additional 535 shares during the period. Security Asset Management lifted its stake in shares of Masimo by 4.4% in the 3rd quarter. Security Asset Management now owns 12,834 shares of the medical equipment provider’s stock valued at $1,598,000 after purchasing an additional 539 shares during the period. Finally, Crossmark Global Holdings Inc. lifted its stake in shares of Masimo by 14.4% in the 2nd quarter. Crossmark Global Holdings Inc. now owns 7,636 shares of the medical equipment provider’s stock valued at $746,000 after purchasing an additional 960 shares during the period. 88.00% of the stock is currently owned by hedge funds and other institutional investors.
A number of research analysts have recently weighed in on MASI shares. BidaskClub downgraded Masimo from a “strong-buy” rating to a “buy” rating in a research note on Saturday, November 3rd. Stifel Nicolaus increased their price target on Masimo from $112.00 to $145.00 and gave the company a “buy” rating in a research note on Tuesday, October 2nd. Needham & Company LLC started coverage on Masimo in a research note on Friday, September 14th. They issued a “buy” rating on the stock. Zacks Investment Research downgraded Masimo from a “buy” rating to a “hold” rating in a research note on Wednesday, August 1st. Finally, Piper Jaffray Companies increased their price target on Masimo to $120.00 and gave the company a “neutral” rating in a research note on Thursday, November 1st. Three research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Masimo presently has a consensus rating of “Buy” and an average target price of $114.40.
Masimo (NASDAQ:MASI) last released its quarterly earnings data on Wednesday, October 31st. The medical equipment provider reported $0.71 EPS for the quarter, beating the Zacks’ consensus estimate of $0.69 by $0.02. Masimo had a net margin of 17.08% and a return on equity of 20.29%. The business had revenue of $210.58 million during the quarter, compared to analysts’ expectations of $207.62 million. During the same quarter in the prior year, the company earned $0.56 EPS. The firm’s quarterly revenue was up 8.9% on a year-over-year basis. On average, research analysts expect that Masimo Co. will post 2.92 earnings per share for the current year.
In related news, CEO Joe E. Kiani sold 239,926 shares of the company’s stock in a transaction on Tuesday, September 4th. The shares were sold at an average price of $117.95, for a total value of $28,299,271.70. Following the completion of the sale, the chief executive officer now owns 236,061 shares in the company, valued at approximately $27,843,394.95. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Sanford Fitch sold 2,000 shares of the company’s stock in a transaction on Thursday, November 1st. The shares were sold at an average price of $113.14, for a total transaction of $226,280.00. The disclosure for this sale can be found here. In the last 90 days, insiders sold 666,033 shares of company stock valued at $79,900,568. 12.60% of the stock is owned by corporate insiders.
COPYRIGHT VIOLATION WARNING: “Janney Montgomery Scott LLC Trims Holdings in Masimo Co. (MASI)” was posted by WKRB News and is the property of of WKRB News. If you are reading this news story on another website, it was copied illegally and republished in violation of U.S. and international trademark & copyright legislation. The legal version of this news story can be read at https://www.wkrb13.com/2018/11/26/janney-montgomery-scott-llc-trims-holdings-in-masimo-co-masi.html.
Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through-motion and low-perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.
Read More: What is the quiet period?
Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Co. (NASDAQ:MASI).
Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.